**Abbreviations:**

PD, Parkinson\'s disease

INTRODUCTION {#sec1-1}
============

Parkinson\'s disease (PD) is a slow-onset neurodegenerative disorder, with selective loss of substantia nigral dopaminergic neurons and significant reduction of striatal dopamine content. The incidence rate of PD rises with age to about 1% in the population of 65 years of age or older\[[@ref1]\]. PD is caused by a decrease in the level of dopamine in the striatum due to degeneration of dopaminergic neurons. At present, drug treatments and surgery cannot fundamentally solve the problem. With the development of cell replacement therapy, medical professionals are exploring treatment by restoration of dopamine neurotransmitters in the neural circuitry of patients with PD by getting dopaminergic neurons and cell transplantation. In 1988, Lindvall *et al*\[[@ref2]\] first used human embryonic midbrain transplantation for the treatment of idiopathic PD. Later, Freed *et al*\[[@ref3]\] transplanted human embryonic midbrain dopaminergic cells into the brains of Parkinson\'s patients, which substantially alleviated the clinical symptoms. The pathogenesis of PD is clear, the anatomical localization of the nucleus related to pathogenesis is explicit, animal models have been established, and the results of some clinical trials are favorable. Therefore, PD is regarded as one of the most treatable diseases by stem cell transplantation\[[@ref4]\]. Transplanted stem cells can infiltrate and integrate with diseased tissue, differentiate into dopaminergic neurons to replace damaged cells and reconstruct neuronal circuits to restore nerve function. Commonly used stem cells to treat PD are neural stem cells, embryonic stem cells and bone marrow mesenchymal stem cells. Reynolds and Weiss\[[@ref5]\] proposed the concept of neural stem cells. However, the generally accepted concept was proposed by Mckay in 1997\[[@ref6]\]. The concept is that neural stem cells have the ability to differentiate into neurons, astrocytes and oligodendrocytes, they can self-renew and generate a large number of neural cell types. Results of induced differentiation *in vitro* show that different conditions can induce neural stem cells to differentiate into different types of neurons, astrocytes and oligodendrocytes. In addition, differentiated neurons have different phenotypes to perform different functions with neurotransmitters. Therefore, neural stem cell transplantation can have an effect on the pathological process of PD. There was a landmark study of embryonic stem cells to treat PD in 2005. Takagi *et al*\[[@ref7]\] carried out directed induced differentiation of rhesus monkey embryonic stem cells, prepared donor cells that were very similar to endogenous dopaminergic neurons, and transplanted them into a monkey model of PD induced by 1-methyl-4-phenyl-tetrahydropyridine. After transplantation, positron emission tomography showed that living transplanted cells were able to exert the function of dopaminergic neurons, and significantly improved behavioral symptoms of the monkey model of PD. The 1-methyl-4-phenyl-tetrahydropyridine-induced PD model is very similar to PD in humans, and the experimental results predict the efficacy of clinical application of cell transplantation accurately\[[@ref8]\]. Experimental results *in vitro* show that after induced differentiation by a specific inducer, adult mouse and human mesenchymal stem cells gradually show the morphological characteristics of neurons and express specific markers of neurons such as neuron-specific enolase\[[@ref9]\]. This observation confirms that mesenchymal stem cells can be induced to differentiate into nerve cells *in vitro* by nerve growth factor and brain-derived nerve growth factor\[[@ref10]\].

Our study is designed to compare different cell sources for stem cell transplantation for treating PD from published research papers found on the Web of Science from 2002 to 2011.

DATA SOURCES AND METHODOLOGY {#sec1-2}
============================

Data retrieval {#sec2-1}
--------------

In this study, we used bibliometric methods to quantitatively and qualitatively investigate research trends in studies of stem cell transplantation for treating PD. For this purpose, we employed the Web of Science, a research database of publications and citations that are selected and evaluated by the Institute for Scientific Information in Philadelphia, PA, USA, using the key words "PD" "neural stem cells" "embryonic stem cells" "bone marrow mesenchymal stem cells" and "cell transplantation". We limited the period of publication from 2002 to 2011 and searched 1 062 results, and downloaded the data on March 20, 2012.

Inclusion criteria {#sec2-2}
------------------

The inclusion criteria were as follows: (1) peer-reviewed articles on stem cell transplantation for treating PD which were published and indexed in the Web of Science, including original research articles, reviews, meeting abstracts, proceedings papers, book chapters, editorial material, and news items; (2) the year of publication was 2002--2011; (3) the citation database was Science Citation Index-Expanded (SCI-E).

Exclusion criteria {#sec2-3}
------------------

We excluded articles that required manual searching or telephone access. We excluded documents that were not published in the public domain. We excluded a number of corrected papers from the total number of articles analyzed.

The outcomes of all articles referring to stem cell transplantation for treating PD were measured using the following criteria: (a) type of literature on stem cell transplantation for treating PD; (b) annual publication output on stem cell transplantation for treating PD; (c) journal publications on stem cell transplantation for treating PD; (d) distribution of subject areas on stem cell transplantation for treating PD by subject area; (e) publications on stem cell transplantation for treating PD according to country; (f) publications on stem cell transplantation for treating PD by institution; (g) comparison of countries that published the most papers on stem cell transplantation from different cell sources for treating PD; (h) comparison of institutions that published the most papers on stem cell transplantation from different cell sources for treating PD; (i) comparison of study results on stem cell transplantation from different cell sources for treating PD.

RESULTS {#sec1-3}
=======

The search results of stem cell transplantation from different cell sources for treating PD from 2002 to 2011 are presented in [Table 1](#T1){ref-type="table"}.

###### 

Number of publications on stem cell transplantation from different sources for treating Parkinson\'s disease from 2002 to 2011

![](NRR-7-1272-g001)

The different types of publications relating to stem cell transplantation for treating PD from 2002 to 2011 are presented in [Table 2](#T2){ref-type="table"}.

###### 

Types of publication on stem cell transplantation for treating Parkinson\'s disease included in the Web of Science from 2002 to 2011

![](NRR-7-1272-g002)

In [Table 2](#T2){ref-type="table"}, it is evident that articles, reviews, and meeting abstracts constituted the major types of publications related to stem cell transplantation for treating PD over this period. There were 713 articles accounting for 67.13% of the total number of publications, which was more than any other type of literature, followed by reviews (248) that accounted for 23.35%.

The annual publication output on stem cell transplantation for treating PD from 2002 to 2011 is presented in [Figure 1](#F1){ref-type="fig"}.

![Annual number of publications on stem cell transplantation for treating Parkinson\'s disease in the Web of Science from 2002 to 2011.](NRR-7-1272-g003){#F1}

There were 1 062 publications on stem cell transplantation for treating PD in the Web of Science from 2002 to 2011. The number of publications on stem cell transplantation for treating PD had gradually increased over the past 10 years. In total, 123 papers were published and included in the Web of Science in 2010, which was much more than that in 2002. However, there was a decrease in the number of papers published in 2005 and 2006.

The top 10 journals that published papers on stem cell transplantation for treating PD from 2002 to 2011 are presented in [Table 3](#T3){ref-type="table"}.

###### 

Top 10 journals that published studies on stem cell transplantation for treating Parkinson\'s disease included in the Web of Science from 2002 to 2011

![](NRR-7-1272-g004)

In [Table 3](#T3){ref-type="table"}, it is evident that most papers on stem cell transplantation for treating PD appeared in journals with a particular focus on neuroscience and stem cell research. Stem Cells published 50 papers that accounted for 4.70% of the total number of publications, followed by *Experimental Neurology* that published 32 papers and accounted for 3.01%.

The distribution of subject areas related to stem cell transplantation for treating PD from 2002 to 2011 is presented in [Table 4](#T4){ref-type="table"}.

###### 

Distribution of subject areas related to stem cell transplantation for treating Parkinson\'s disease included in the Web of Science from 2002 to 2011
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In [Table 4](#T4){ref-type="table"}, it is evident that among the subject categories related to stem cell transplantation for treating PD, the greatest number of studies (493 papers) was in the field of neuroscience, which accounted for 46.42%. With 244 papers, the second highest number of studies was in the field of cell biology, which accounted for 22.97%.

The country distribution of publications on stem cell transplantation for treating PD from 2002 to 2011 according to the country is presented in [Table 5](#T5){ref-type="table"}.

###### 

Top 10 countries in terms of number of studies on stem cell transplantation for treating Parkinson\'s disease included in the Web of Science from 2002 to 2011
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In [Table 5](#T5){ref-type="table"}, it is clear that the United States published the highest number of papers on stem cell transplantation for treating PD. The United States published 385 papers that accounted for 36.25% of the total, which is much higher than the number of papers published by other countries. Germany ranked second with 105 papers and accounted for 9.88%.

The number of publications on stem cell transplantation for treating PD from 2002 to 2011 according to the institution in presented in [Table 6](#T6){ref-type="table"}.

###### 

Top 14 institutions publishing studies on stem cell transplantation for treating Parkinson\'s disease in the Web of Science from 2002 to 2011
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In [Table 6](#T6){ref-type="table"}, it is evident that the top institution for studies on stem cell transplantation for treating PD is Harvard University, followed by Lund University and the Karolinska Institute.

The comparison of countries and institutions that published the most papers on stem cell transplantation from different cell sources for treating PD from 2002 to 2011 is shown in Tables [7](#T7){ref-type="table"} and [8](#T8){ref-type="table"}.

###### 

Comparison of countries that published most papers on transplantation of stem cells from different sources for treating Parkinson\'s disease in the Web of Science from 2002 to 2011
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###### 

Comparison of institutions that published most papers on transplantation of stem cells from different sources for treating Parkinson\'s disease in the Web of Science from 2002 to 2011
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The analysis of articles on neural stem cell transplantation for treating PD from 2002 to 2011 is shown in Tables [9](#T9){ref-type="table"} and [10](#T10){ref-type="table"}.

###### 

Most cited articles on neural stem cell transplantation for treating Parkinson\'s disease in the Web of Science from 2002 to 2011
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###### 

Studies on neural stem cell transplantation for treating Parkinson\'s disease

![](NRR-7-1272-g011)

The analysis of articles on embryonic stem cell transplantation for treating PD from 2002 to 2011 is shown in Tables [11](#T11){ref-type="table"} and [12](#T12){ref-type="table"}.

###### 

Most cited articles on embryonic stem cell transplantation for treating Parkinson\'s disease in the Web of Science from 2002 to 2011
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###### 

Studies on embryonic stem cell transplantation for treating Parkinson\'s disease
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The analysis of articles on bone marrow mesenchymal stem cell transplantation for treating PD from 2002 to 2011 is shown in Tables [13](#T13){ref-type="table"} and [14](#T14){ref-type="table"}.

###### 

Most cited articles on bone marrow mesenchymal stem cell transplantation for treating Parkinson\'s disease in the Web of Science from 2002 to 2011

![](NRR-7-1272-g014)

###### 

Studies on bone marrow mesenchymal stem cell transplantation for treating Parkinson\'s disease

![](NRR-7-1272-g015)

DISCUSSION {#sec1-4}
==========

Based on the bibliometric analysis, the following comparisons and results were obtained regarding stem cell transplantation for treating PD.

First, there are 1 062 research articles addressing stem cell transplantation for treating PD included in the Web of Science from 2002 to 2011. The research on stem cell transplantation for treating PD is attracting ever-increasing attention among global researchers from 2002, notwithstanding slight drops in outputs in 2005 and 2011.

Second, subject categories including neuroscience and cell biology are involved in stem cell transplantation for treating PD. Because of this broad range, scholars and surgeons in these areas work hard and readily publish articles on stem cell transplantation for treating PD.

Third, journals focusing on neuroscience published the most articles concerning stem cell transplantation for treating PD, and Stem Cells has the highest total number of publications.

The most cited paper is not necessarily the highest impact paper on an annual basis. The immediate impact during the year when they were published is indicated by the average citation per annum or the citation during each year.

Much attention and effort has been devoted to stroke treatment and rehabilitation using stem cell transplantation. The findings of the present study may be of interest to fellow researchers who are currently undertaking studies on stem cell transplantation for treating PD or those who may do so in the future.
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